When hospitals discharge patients into skilled nursing or home care, time is of the essence — yet decisions are still made using bloated PDFs, fragmented faxes, and overloaded staff. ExaCare AI believes that’s an outdated way to run one of healthcare’s most critical handoffs. Now, with a fresh $30 million Series A in hand, it’s building a team of AI agents to radically streamline the post-acute care workflow.
The funding round, announced on October 16, 2025, was led by Insight Partners, with participation from Foundation Capital, Bienville Capital, and a select group of healthcare operators. The New York-based startup already supports over 1,500 skilled nursing facilities and is now preparing to scale up its engineering, product development, and go-to-market teams to meet growing demand.
“Powerful AI agents will work alongside every team to turn scattered data into clear next steps,” said Laird Russell, CEO and cofounder of ExaCare AI. “When every decision is auditable, every handoff is complete, and every workflow adapts in real time, caregivers can focus entirely on people and outcomes.”
ExaCare is targeting a longstanding operational pain point in the post-acute sector: the messy, inconsistent process of handling patient referrals and admissions. Referral packets often arrive as long, unstructured documents — rife with missing data and critical clinical details buried in pages of irrelevant information. The result? Delays, revenue leakage, and staff burnout.
Its product uses custom-built AI models to ingest these packets, extract decision-critical data, and generate standardized, auditable recommendations. The platform is expanding into a suite of specialized AI agents, each handling a specific operational function:
Admissions Agent: Parses referrals, aligns patients with facility criteria, and recommends disposition paths with traceable justifications.
Reimbursement Agent: Helps staff ensure accurate documentation and coding across Medicare, Medicaid, and managed care — reducing the risk of denials.
Clinical Agent: Surfaces a patient’s care history across multiple providers to guide optimal care planning.
Survey Readiness Agent: Flags documentation gaps, regulatory risks, and readiness for state inspections.
Documentation Agent: Standardizes notes and forms, attaches evidence, and ensures clean records throughout the care episode.
These agents are built with auditability, role-based access, and compliance safeguards baked in — key considerations in the highly regulated post-acute space.
Backing from industry insiders bolsters the company’s legitimacy. New strategic advisors include Ephram Ostreicher (COO, National Healthcare Associates), Bernie McGuinness and Austin Steele from Journey Healthcare, Tim Fields (CEO, Ignite Medical Resorts), and Renee Pruzansky (VP, Infinite Care) — all deeply embedded in post-acute operations.
The company also announced the ExaCare AI Summit, to be held on April 25, 2026, at The Phoenician in Scottsdale, Arizona. It will bring together CEOs, operators, clinicians, and technologists to preview the company’s roadmap and demonstrate use cases of its AI agents in real-world facilities.
A Tectonic Shift Waiting to Happen
ExaCare is placing a deliberate bet on the overlooked backbone of healthcare: the post-acute sector, where operations remain mired in manual workflows, yet decisions often carry high stakes for patient outcomes and facility finances. It’s a segment under relentless staffing pressure and tight reimbursement models — fertile ground for AI tools that can reduce friction, improve reliability, and surface insight at speed.
Its “agentic” approach is not about replacing clinical staff, but augmenting them — automating what’s automatable so that humans can do what only they can. This framing will be crucial in gaining buy-in from an industry wary of tech-driven disruption. The challenge, of course, lies in real-world implementation: no AI system thrives without clean integrations, change management, and consistent trust from users.
But if ExaCare succeeds in standardizing and accelerating admissions decisions, the impact could ripple outward: faster transitions from hospitals, better patient outcomes, improved margins, and staff who can finally shift their attention from paperwork to care delivery. In a fragmented, margin-sensitive sector, that’s a proposition that will be hard to ignore.
If you need further assistance or have any corrections, please reach out to editor@thetimesmag.com.
